Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jun;40(3):88.
doi: 10.18773/austprescr.2017.033. Epub 2017 Jun 1.

Pharmacokinetics of apixaban

Affiliations
Comment

Pharmacokinetics of apixaban

Penny Beirne. Aust Prescr. 2017 Jun.
No abstract available

PubMed Disclaimer

Comment on

  • Long-term prescribing of new oral anticoagulants.
    Chin PK, Doogue MP. Chin PK, et al. Aust Prescr. 2016 Dec;39(6):200-204. doi: 10.18773/austprescr.2016.068. Epub 2016 Dec 5. Aust Prescr. 2016. PMID: 27990047 Free PMC article. Review. No abstract available.

References

    1. Chin PK, Doogue MP. Long-term prescribing of new oral anticoagulants. Aust Prescr 2016;39:200-4. https://doi.org/10.18773/austprescr.2016.068 10.18773/austprescr.2016.068 - DOI - PMC - PubMed
    1. Frost C, Boyd RA. The contribution of apixaban renal clearance to total clearance. J Thromb Thrombolysis 2015;40:521-2. https://doi.org/10.1007/s11239-015-1220-8 10.1007/s11239-015-1220-8 - DOI - PMC - PubMed
    1. Hellfritzsch M, Damkier P, Pottegård A, Grønlykke T, Grove EL. Inconsistencies in reporting of renal elimination among NOACs: the case of apixaban. Pharmacoepidemiol Drug Saf 2016;25:346-8. https://doi.org/10.1002/pds.3916 10.1002/pds.3916 - DOI - PubMed
    1. Raghavan N, Frost CE, Yu Z, He K, Zhang H, Humphreys WG, et al. Apixaban metabolism and pharmacokinetics after oral administration to humans. Drug Metab Dispos 2009;37:74-81. https://doi.org/10.1124/dmd.108.023143 10.1124/dmd.108.023143 - DOI - PubMed
    1. Vakkalagadda B, Frost C, Byon W, Boyd RA, Wang J, Zhang D, et al. Effect of rifampin on the pharmacokinetics of apixaban, an oral direct inhibitor of factor Xa. Am J Cardiovasc Drugs 2016;16:119-27. https://doi.org/10.1007/s40256-015-0157-9 10.1007/s40256-015-0157-9 - DOI - PubMed

LinkOut - more resources